High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial (Q35639207)
Jump to navigation
Jump to search
scientific article published on 12 October 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial |
scientific article published on 12 October 2011 |
Statements
1 reference
High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial (English)
1 reference
Connie Celum
1 reference
Jared M Baeten
1 reference
Nelly R Mugo
1 reference
Kenneth Ngure
1 reference
Kenneth Mugwanya
1 reference
Elizabeth Irungu
1 reference
12 October 2011
1 reference
1 reference
204
1 reference
12
1 reference
1912-1917
1 reference
Identifiers
1 reference
1 reference
1 reference